JP2002533680A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533680A5
JP2002533680A5 JP2000589950A JP2000589950A JP2002533680A5 JP 2002533680 A5 JP2002533680 A5 JP 2002533680A5 JP 2000589950 A JP2000589950 A JP 2000589950A JP 2000589950 A JP2000589950 A JP 2000589950A JP 2002533680 A5 JP2002533680 A5 JP 2002533680A5
Authority
JP
Japan
Prior art keywords
albumin
denatured
progress
minutes
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000589950A
Other languages
English (en)
Japanese (ja)
Other versions
JP4160263B2 (ja
JP2002533680A (ja
Filing date
Publication date
Priority claimed from AUPP7843A external-priority patent/AUPP784398A0/en
Application filed filed Critical
Priority claimed from PCT/IB1999/002029 external-priority patent/WO2000037944A1/en
Publication of JP2002533680A publication Critical patent/JP2002533680A/ja
Publication of JP2002533680A5 publication Critical patent/JP2002533680A5/ja
Application granted granted Critical
Publication of JP4160263B2 publication Critical patent/JP4160263B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000589950A 1998-12-21 1999-12-20 尿サンプル中の所定のタンパク質の全含有量を測定する方法 Expired - Fee Related JP4160263B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPP7843A AUPP784398A0 (en) 1998-12-21 1998-12-21 Kidney disease detection and treatment
US09/415,217 1999-10-12
US7843 1999-10-12
US09/415,217 US6447989B1 (en) 1998-12-21 1999-10-12 Kidney disease detection and treatment
PCT/IB1999/002029 WO2000037944A1 (en) 1998-12-21 1999-12-20 Kidney disease detection and treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005270160A Division JP4388515B2 (ja) 1998-12-21 2005-09-16 腎臓病の検出方法

Publications (3)

Publication Number Publication Date
JP2002533680A JP2002533680A (ja) 2002-10-08
JP2002533680A5 true JP2002533680A5 (https=) 2005-09-22
JP4160263B2 JP4160263B2 (ja) 2008-10-01

Family

ID=25645955

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000589950A Expired - Fee Related JP4160263B2 (ja) 1998-12-21 1999-12-20 尿サンプル中の所定のタンパク質の全含有量を測定する方法
JP2005270160A Expired - Fee Related JP4388515B2 (ja) 1998-12-21 2005-09-16 腎臓病の検出方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005270160A Expired - Fee Related JP4388515B2 (ja) 1998-12-21 2005-09-16 腎臓病の検出方法

Country Status (13)

Country Link
US (3) US20020012906A1 (https=)
EP (1) EP1141728B1 (https=)
JP (2) JP4160263B2 (https=)
CN (1) CN1331801A (https=)
AT (1) ATE376187T1 (https=)
AU (1) AU1674400A (https=)
BR (1) BR9916407A (https=)
CA (1) CA2356174A1 (https=)
DE (1) DE69937368T2 (https=)
DK (1) DK1141728T3 (https=)
IL (1) IL143892A0 (https=)
MX (1) MXPA01006404A (https=)
WO (1) WO2000037944A1 (https=)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP784398A0 (en) 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
ATE376187T1 (de) 1998-12-21 2007-11-15 Univ Monash Nachweis von erkrankungen der nieren und behandlung
US7250294B2 (en) * 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
PT1384075E (pt) 2001-03-28 2010-03-23 Heska Corp Métodos de detecção de doença renal inicial em animais
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
WO2004084841A2 (en) 2003-03-27 2004-10-07 Heska Corporation Novel anti-feline albumin antibodies and methods of detecting early renal disease
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
WO2005016111A2 (en) 2003-08-08 2005-02-24 Abgenix, Inc. Antibodies directed to parathyroid hormone (pth) and uses thereof
US20050112123A1 (en) * 2003-10-06 2005-05-26 Vaughan Michael R. Methods of treating proteinuria
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
US8148325B2 (en) * 2004-12-30 2012-04-03 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US20060205818A1 (en) * 2005-03-08 2006-09-14 Burzynski Stanislaw R Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives
BRPI0610731A2 (pt) * 2005-04-19 2012-10-30 Hills Pet Nutrition Inc composição, método para evitar ou tratar doença do rim, conjunto para a administração de uma composição de prevenção ou tratamento de doenças do rim ao paciente, método para a promoção da saúde do rim, meios para a comunicação de informação a respeito ou instruções para a mistura e a administração de uma ou mais das composições, componentes da composição, composições alimentìcias, ingredientes alimentìcios, e drogas renais, e para a utilização de dispositivos de diagnósticos renal da presente invenção, e, uso de uma composição
CA2605855A1 (en) * 2005-04-29 2006-11-09 Hill's Pet Nutrition, Inc. Methods for prolonging feline life
JP5289942B2 (ja) * 2005-05-20 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 成年動物の健康または健全を促進する方法
EP1896070A4 (en) * 2005-06-29 2009-04-29 Hills Pet Nutrition Inc METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF RENAL DISEASE
US8492432B2 (en) * 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
JP5351773B2 (ja) * 2007-03-07 2013-11-27 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 尿試料中の検体の濃度を正規化するための方法
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US9000134B2 (en) * 2007-05-11 2015-04-07 Wallace B. Haigh Reagent and kit for early diagnosis of kidney disease
WO2009047280A2 (de) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnose von prostatakrebs
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
US20120037507A9 (en) * 2008-03-19 2012-02-16 Harald Mischak Method and marker for diagnosis of tubular kidney damage and illnesses
EP2313778B1 (en) 2008-07-18 2015-01-28 Boston Medical Center Corporation Diagnostics for membranous nephropathy
JP2012501456A (ja) * 2008-08-28 2012-01-19 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
EP2324354B1 (en) * 2008-08-29 2014-07-16 Astute Medical, Inc. Methods for prognosis of acute renal failure
EP2338054A1 (de) * 2008-09-17 2011-06-29 Mosaiques Diagnostics And Therapeutics AG Nierenzellkarzinom
ES2836218T3 (es) 2008-10-21 2021-06-24 Astute Medical Inc Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
CA2740923A1 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2913676A1 (en) 2008-11-10 2015-09-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009316387B2 (en) * 2008-11-22 2015-01-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010064239A1 (en) 2008-12-04 2010-06-10 Technion Research And Development Foundation Ltd. Apparatus and methods for diagnosing renal disorders
BRPI1007483B1 (pt) * 2009-01-28 2021-11-30 Bio Preventive Medicine Corporation Método de diagnóstico de nefropatia in vitro, método in vitro para o monitoramento de progresso de nefropatia, método in vitro para o monitoramento da eficácia de um tratamento de nefropatia, método in vitro de avaliação de toxicidade renal de um agente e kit para diagnóstico de nefropatia
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010279249B2 (en) * 2009-02-06 2015-08-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120315649A1 (en) * 2009-08-28 2012-12-13 Astute Medical ,Inc. a corporation Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ600160A (en) * 2009-11-07 2014-05-30 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010315008B2 (en) 2009-11-07 2015-12-03 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011075744A1 (en) 2009-12-20 2011-06-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011213684B2 (en) 2010-02-05 2014-11-20 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ701807A (en) 2010-02-26 2015-05-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
IN2012MN02812A (https=) 2010-06-23 2015-05-22 Astute Medical Inc
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8930222B2 (en) * 2010-08-05 2015-01-06 Abbott Laboratories Method and system for managing patient healthcare
DE102010038014B4 (de) * 2010-10-06 2021-10-07 Numares Ag Verwendung spezifischer Substanzen als Marker zur Bestimmung des Risikos einer Nierenabstoßung
KR101215759B1 (ko) 2010-11-01 2012-12-26 서울대학교산학협력단 오로소뮤코이드를 포함하는 조성물의 용도
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102854325B (zh) * 2011-07-01 2015-01-07 复旦大学 胰岛素与血清蛋白可逆性结合的亲和力指标测定方法及应用
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US20130115640A1 (en) * 2011-11-03 2013-05-09 James A. Tumlin ACTH for Treatment of Kidney Disease
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
US9689826B2 (en) 2012-03-11 2017-06-27 Technion Research And Development Foundation Ltd. Detection of chronic kidney disease and disease progression
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP3361255B1 (en) 2013-01-17 2020-03-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
CN104007258B (zh) * 2013-09-30 2016-07-06 中国医学科学院基础医学研究所 局灶性节段性肾小球硬化的蛋白标志物
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CN110007084B (zh) 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
CN104849466A (zh) * 2014-02-14 2015-08-19 张曼 尿液玻璃体结合蛋白在2型糖尿病合并早期肾损伤诊治中的应用
CA2955992A1 (en) * 2014-07-23 2016-01-28 University Of British Columbia Biomarkers for anderson-fabry disease
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US11243202B2 (en) 2015-04-09 2022-02-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
US11026625B2 (en) 2017-08-08 2021-06-08 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
CN107561175A (zh) * 2017-08-10 2018-01-09 武汉大学 一种肾小球硬化大鼠模型的评价方法
RU2697722C1 (ru) * 2018-12-06 2019-08-19 Ирина Сергеевна Шатохина Способ диагностики активности воспалительного процесса при латентном течении хронического пиелонефрита
CN110632229A (zh) * 2019-09-24 2019-12-31 华兰生物工程重庆有限公司 高效液相色谱仪检测静注人免疫球蛋白(pH4)蛋白质含量的方法
CN111714517A (zh) * 2020-04-14 2020-09-29 南开大学 一种溶酶体作为制备药物领域的应用
RU2768464C1 (ru) * 2021-04-27 2022-03-24 Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ диагностики мембранозной нефропатии как одной из форм хронического гломерулонефрита

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994165A (en) * 1989-02-16 1991-02-19 Cornell Research Foundation, Inc. Liquid junction coupling for capillary zone electrophoresis/ion spray spectrometry
EP0514928B1 (en) * 1991-05-24 1997-08-20 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases by detecting albumin fragments
JPH0682446A (ja) * 1992-08-31 1994-03-22 Wakamoto Pharmaceut Co Ltd 腎疾患の診断法
DE4336498A1 (de) * 1993-10-26 1995-04-27 Bender & Co Gmbh Verfahren zur Diagnose von Nieren- und Gefäßerkrankungen
US5534431A (en) * 1994-02-28 1996-07-09 The Board Of Regents Of The University Of Nebraska Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof
US5908925A (en) 1996-06-27 1999-06-01 Exocell, Inc. Genetically engineered immunoglobulins with specificity for glycated albumin
US5800998A (en) * 1996-11-12 1998-09-01 Millennium Pharmaceuticals, Inc. Assays for diagnosing type II diabetes in a subject
ATE376187T1 (de) 1998-12-21 2007-11-15 Univ Monash Nachweis von erkrankungen der nieren und behandlung

Similar Documents

Publication Publication Date Title
JP2002533680A5 (https=)
JP4388515B2 (ja) 腎臓病の検出方法
Pickup et al. Serum sialic acid concentration and coronary heart disease in NIDDM
WO2001075454A3 (en) Diagnosis and treatment of alzheimer's disease
KR20040032826A (ko) 단백질 프로파일링에 의한 신장 질병 검출 방법
EP2330219A3 (en) Method for drug discovery, disease treatment and diagnosis using metabolomics
WO2002082075A3 (de) Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
Diana et al. Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin
WO2002046222A3 (en) Compositions and methods for diagnosing alzheimer's disease
WO2002059604A3 (en) Diagnosis and treatment of multiple sclerosis
JP2020519904A5 (https=)
WO2003048775A3 (de) Peptide und verfahren zum nachweis von morbus alzheimer und zur unterscheidung von morbus alzheimer gegenüber anderen demenziellen erkrankungen
WO2003028543A3 (en) Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
JP2003510286A5 (https=)
Lee et al. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin
Gioldassi et al. Clara cell secretory protein: determination of serum levels by an enzyme immunoassay and its importance as an indicator of bronchial asthma in children
JP2001517456A5 (https=)
Ono et al. Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications
WO2004071273A3 (en) Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
DK0683791T3 (da) Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf
WO2001063293A8 (en) Diagnosis and treatment of schizophrenia
HK1045944A1 (zh) 基於抗体亲和力的狼疮治疗方法和筛选方法及用於其的组合物
Massol et al. Letter to the Editor regarding'Impact of Continuous Renal Replacement Therapy with Polyacrylonitrile-Derived Filter on Caspofungin Concentration: A Retrospective Study'
Karol et al. Lansoprazole pharmacokinetics in subjects with various degrees of kidney function
JP3876300B2 (ja) 好酸球カチオン性タンパク質（イソ―ｅｃｐ）の分子形態検出用診断法